Found 5 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Phaseā
”Clinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) PHASE2 The Phase II clinical trial of the oral hexavalent reassortant rotavirus at...
Show More Location
Hubei Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization PHASE3 The first multicenter prospective, randomized, double-blind, placebo-contro...
Show More Location
Perm State Medical University named after Academician E.A. Wagner
Learn More & Join Trial
Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger PHASE3 The study is a double-blinded, randomized, placebo-controlled, trial with t...
Show More Location
Madarounfa Health District
Learn More & Join Trial
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid⢠(Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. PHASE3 The purpose of the presented study was to evaluate the safety and immunolog...
Show More Location
Perm State Medical University named after Academician E.A. Wagner
Learn More & Join Trial